Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

1,25-dihydroxycholecalciferol in hypoparathyroidism.

M Davies, C M Taylor, L F Hill

Lancet (London, England)

|January 8, 1977

Summary

This study shows that 1,25-dihydroxycholecalciferol effectively normalized serum calcium in hypoparathyroidism patients. While it reduced phosphorus, some patients still required calcium supplements and had persistent high phosphorus levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An open-source workflow for identifying hydrodynamic water quality events in rivers by continuous water quality monitoring and time-series data processing using R and US EPA CANARY.

MethodsX·2025

Same author

Do Children Who Were Preschool Picky Eaters Eat Different Foods at School Lunch When Aged 13 Years Than Their Non-Picky Peers?

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2025

Same author

Seafood intake in children at age 7 years and neurodevelopmental outcomes in an observational cohort study (ALSPAC).

European journal of nutrition·2025

Same author

Limosilactobacillus reuteri ameliorates maternal separation stress in newborn mice and alters subsequent adult behaviour.

Beneficial microbes·2024

Same author

Association of behavioural and social-communicative profiles in children with 16p11.2 copy number variants: a multi-site study.

Journal of intellectual disability research : JIDR·2024

Same author

Aluminum-induced generation of lipopolysaccharide (LPS) from the human gastrointestinal (GI)-tract microbiome-resident Bacteroides fragilis.

Journal of inorganic biochemistry·2019

Area of Science:

Endocrinology
Nephrology
Metabolic Bone Disease

Background:

Hypoparathyroidism is a condition characterized by insufficient parathyroid hormone production, leading to hypocalcemia and hyperphosphatemia.
Current management often involves calcium and vitamin D supplementation, but achieving optimal biochemical control can be challenging.

Purpose of the Study:

To evaluate the efficacy and safety of 1,25-dihydroxycholecalciferol in treating hypoparathyroidism.
To compare the effects of 1,25-dihydroxycholecalciferol with conventional oral calcium therapy.

Main Methods:

A cohort of 8 patients with hypoparathyroidism received 1,25-dihydroxycholecalciferol at doses ranging from 0.25 to 1.0 mug/day for 4 to 24 months.
Serum calcium and phosphorus levels, as well as renal tubular reabsorption of phosphate, were monitored throughout the treatment period.

Main Results:

Normal serum calcium levels were achieved in all 8 patients, with 50% requiring additional oral calcium.
Serum phosphorus levels were reduced in all patients, but remained elevated in 3 patients.
Normal renal tubular reabsorption of phosphate was observed in only 2 out of 8 patients.

Conclusions:

1,25-dihydroxycholecalciferol is an effective treatment for normalizing serum calcium in hypoparathyroidism.
While beneficial for phosphorus levels, its effect on renal phosphate handling is variable, and some patients may still require supplementary calcium.
Further research is needed to fully elucidate the therapeutic mechanisms of 1,25-dihydroxycholecalciferol in this condition.

Related Experiment Videos